Authors
Jannik Stemler, Kamal Hamed, Jon Salmanton‐García, Ali Rezaei‐Matehkolaei, Stefanie K Graefe, Ertan Sal, Marouan Zarrouk, Danila Seidel, Reham Abdelaziz Khedr, Ronen Ben‐Ami, Eli Ben‐Chetrit, Yehudah Roth, Oliver A Cornely
Publication date
2020/10
Journal
Mycoses
Volume
63
Issue
10
Pages
1060-1068
Description
Background
Regional differences in the underlying causes, manifestations and treatment of mucormycosis have been noted in studies covering Europe, Asia and South America.
Objectives
To review cases of mucormycosis across the Middle East and North Africa (MENA) region in order to identify epidemiological, treatment and outcome trends in this region.
Patients/Methods
Cases of proven or probable invasive mucormycosis from the region were identified from the FungiScope® database and the medical literature. For each case, information on underlying condition, site of infection, pathogenic species, therapeutic intervention, type of antifungal therapy and outcome were analysed.
Results
We identified 310 cases of mucormycosis in the MENA region. The number of reported cases increased by decade from 23 before 1990 to 127 in the 2010s. In this region, the most common underlying conditions …
Scholar articles
J Stemler, K Hamed, J Salmanton‐García… - Mycoses, 2020